A leading driver and strong advocate for European Businesses in Korea
ECCK Announces Re-election of Dr. Ana-Maria Boie as Healthcare Committee Chair
ECCK is pleased to announce that Dr. Ana-Maria Boie, General Manager of Boehringer Ingelheim Korea has been re-elected as the Chair of the ECCK Healthcare Committee. She will serve a two-year term as the chair, effective from April 25, 2026.
Dr. Ana-Maria Boie, a Romanian national, serves as the General Manager at Boehringer Ingelheim Korea. With over 25 years of experience in the pharmaceutical industry, she has held leadership roles across general management, marketing, sales, and ESG at local, regional, and global levels. She earned her medical degree from the Carol Davila University of Medicine and Pharmacy and later completed an Executive MBA at Tiffin University enhancing her expertise in both medical and business domains. Since joining Boehringer Ingelheim in 2009, she has worked in Romania, Austria, Russia, and Germany, leading key business strategies and contributing to the company’s global sustainability initiatives.
We once again extend our warm congratulations to Dr. Ana-Maria Boie and look forward to her leadership and meaningful contributions in further strengthening and advancing the work of the Healthcare Committee.
ECCK Announces Re-election of Dr. Ana-Maria Boie as Healthcare Committee Chair
ECCK is pleased to announce that Dr. Ana-Maria Boie, General Manager of Boehringer Ingelheim Korea has been re-elected as the Chair of the ECCK Healthcare Committee. She will serve a two-year term as the chair, effective from April 25, 2026.
Dr. Ana-Maria Boie, a Romanian national, serves as the General Manager at Boehringer Ingelheim Korea. With over 25 years of experience in the pharmaceutical industry, she has held leadership roles across general management, marketing, sales, and ESG at local, regional, and global levels. She earned her medical degree from the Carol Davila University of Medicine and Pharmacy and later completed an Executive MBA at Tiffin University enhancing her expertise in both medical and business domains. Since joining Boehringer Ingelheim in 2009, she has worked in Romania, Austria, Russia, and Germany, leading key business strategies and contributing to the company’s global sustainability initiatives.
We once again extend our warm congratulations to Dr. Ana-Maria Boie and look forward to her leadership and meaningful contributions in further strengthening and advancing the work of the Healthcare Committee.